Diagnostic Value of ABO Blood Group Combined with Tumor Markers in Gastric Cancer

Yuhuan Liu,Shasha Chen,Weina Shen,Xiaodong Qu,Songbo Li,Yongquan Shi
DOI: https://doi.org/10.21203/rs.3.rs-2192622/v1
2022-01-01
Abstract:Abstract Background Blood type is related to the occurrence and development of gastric cancer. The aim of this study is to explore the value of combined detection of ABO blood group and tumor markers in the diagnosis of gastric cancer. Methods A total of 3650 gastric cancer patients treated in our center from January 2015 to December 2019, and 5822 controls were recruited, and divided into training set and validation set according to 7:3. The clinicopathological characteristics were recorded. Receiver operating characteristic curve (ROC curve) was used to evaluate the diagnostic value of tumor markers and their combined blood type for gastric cancer. The results were validated using another group of people (validation group). Results In both the training set and the validation set, the levels of tumor markers in gastric cancer patients were higher than those in the healthy control group (P < 0.05). The distribution of blood group in gastric cancer group was: A > B > O > AB, while that in healthy control group was: B > O > A > AB. Type B blood (AUC = 0.850,95%CI 0.837–0.863, P = 0.0006) and type AB blood (AUC = 0.837,95%CI 0.812–0.860, P = 0.0439) could improve the diagnostic value of CEA in gastric cancer. Conclusion The detection of blood group combined with tumor markers can improve the sensitivity and specificity for the diagnosis of gastric cancer, which has a high reference value for the diagnosis of gastric cancer patients, and is worthy of further clinical study.
What problem does this paper attempt to address?